IDEAYA Biosciences Inc (NAS:IDYA)
$ 30.98 -1 (-3.13%) Market Cap: 2.68 Bil Enterprise Value: 1.86 Bil PE Ratio: 0 PB Ratio: 2.27 GF Score: 28/100

IDEAYA Biosciences Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 14, 2023 / 05:20PM GMT
Release Date Price: $15.91 (-0.50%)
Matt Biegler
Oppenheimer & Co. Inc. - Analyst

Hey, good afternoon, everyone. Welcome to OpCo's Healthcare Conference.

Super pumped to be joined by our next speakers who are from IDEAYA, which is one of my favorite covered companies. We've got some of the brains of the operation here: Mike White, who's CSO; and Darrin, who's CMO. I'm excited to talk about some of the recent progress.

Questions & Answers

Matt Biegler
Oppenheimer & Co. Inc. - Analyst

We've only got 30 minutes, though. So Mike, I guess I'll start with you. What kind of differentiates IDEAYA's synthetic lethality core tech or platform -- discovery platform from the rest? You apparently came from Pfizer, what attracted you to the company?

Mike White
IDEAYA Biosciences, Inc. - Chief Scientific Officer

Thanks. Thanks, Matt. So I'll be fast. I know you have a lot you want to get to. First, thanks so much for inviting us to your health conference here today.

As you know, IDEAYA is a precision medicine oncology company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot